4 results match your criteria: "France [3] Centre Hospitalier Universitaire de Nice[Affiliation]"

Low Molecular Weight Heparin in Liver Transplant Recipients After Sleeve Gastrectomy.

Liver Transpl

October 2021

University Côte d'Azur Nice France Centre Hospitalier Universitaire de Nice-Digestive Surgery and Liver Transplantation Division Archet 2 Hospital Nice France Inserm U1065, Team 8 "Hepatic complications of obesity and alcohol" Nice France Department of Medical and Surgical Sciences and Translational MedicineFaculty of Medicine and Psychology St. Andrea Hospital, Sapienza University Rome Italy.

View Article and Find Full Text PDF

[Developmental and environnemental origin of male infertility: role of endocrine disruptors].

Med Sci (Paris)

January 2016

Inserm, U1065, centre méditerranéen de médecine moléculaire (C3M), équipe 5, Centre hospitalier l'Archet 2, 151, route St Antoine Ginestière, Nice, F-06204, France - Université de Nice-Sophia, UFR médecine, Nice, F-06000, France - Centre hospitalier universitaire de Nice, pôle digestif reproduction, CECOS, Nice, F-06202, France.

Human and wildlife exposure to chemicals is thought to be extensive and particularly to endocrine-disrupting chemicals (EDCs) suspected to alter male reproductive tract. When the exposure occurs during perinatal period (fetal, neonatal periods or puberty) the reproductive health alterations are irreversible suggesting a developmental origin to male infertility. This concept is supported by numerous epidemiologic and experimental studies.

View Article and Find Full Text PDF

Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1.

EMBO Mol Med

June 2015

Inserm, U1068, CRCM, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France CNRS, UMR7258, CRCM, Marseille, France

The metabolic syndrome covers metabolic abnormalities including obesity and type 2 diabetes (T2D). T2D is characterized by insulin resistance resulting from both environmental and genetic factors. A genome-wide association study (GWAS) published in 2010 identified TP53INP1 as a new T2D susceptibility locus, but a pathological mechanism was not identified.

View Article and Find Full Text PDF

Objective: Under both physiological and pathological conditions, bone volume is determined by the rate of bone formation by osteoblasts and bone resorption by osteoclasts. Excessive bone loss is a common complication of human IBD whose mechanisms are not yet completely understood. Despite the role of activated CD4(+) T cells in inflammatory bone loss, the nature of the T cell subsets involved in this process in vivo remains unknown.

View Article and Find Full Text PDF